𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Fetal muscle biopsy as a diagnostic tool in Duchenne muscular dystrophy

✍ Scribed by Yoram Nevo; Ruth Shomrat; Yuval Yaron; Avi Orr-Urtreger; Shaul Harel; Cyril Legum

Publisher
John Wiley and Sons
Year
1999
Tongue
English
Weight
184 KB
Volume
19
Category
Article
ISSN
0197-3851

No coin nor oath required. For personal study only.

✦ Synopsis

Duchenne muscular dystrophy (DMD) is a relentless progressive disorder, leading to severe disability during childhood and death in adolescence or early adulthood. In most families, prenatal diagnosis is readily achieved by molecular detection of DNA deletions using chorionic villi or amniocytes, or by linkage analysis. In some cases, however, molecular methods fail to provide a definitive diagnosis and in such cases in utero fetal muscle biopsy may serve as a diagnostic option. We describe three families in whom fetal muscle biopsy was performed, focusing on the prenatal diagnostic dilemmas, the indications and timing for in utero fetal muscle biopsy, and the difficulties encountered.

πŸ“œ SIMILAR VOLUMES

Increase in fetal breech presentation in
Increase in fetal breech presentation in female carriers of Duchenne muscular dystrophy
✍ Geifman-Holtzman, Ossie; Bernstein, Ira M.; Capeless, Eleanor L.; Hawley, Pamela πŸ“‚ Article πŸ“… 1997 πŸ› John Wiley and Sons 🌐 English βš– 17 KB πŸ‘ 2 views

Female carriers of Duchenne muscular dystrophy (DMD) may demonstrate elevated serum creatine kinase (CK) and reduction of muscle dystrophin in all muscle types. We hypothesized that decreased dystrophin in uterine or pelvic girdle musculature might affect the obstetrical performance of females heter

The 6-minute walk test as a new outcome
The 6-minute walk test as a new outcome measure in Duchenne muscular dystrophy
✍ Craig M. McDonald; Erik K. Henricson; Jay J. Han; R. Ted Abresch; Alina Nicorici πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 437 KB

## Abstract Walking abnormalities are prominent in Duchenne muscular dystrophy (DMD). We modified the 6‐minute walk test (6MWT) for use as an outcome measure in patients with DMD and evaluated its performance in 21 ambulatory boys with DMD and 34 healthy boys, ages 4 to 12 years. Boys with DMD were